Literature DB >> 25200986

The role of cortisol in first episode of psychosis: a systematic review.

Evangelos Karanikas1, Diomidis Antoniadis, George D Garyfallos.   

Abstract

The stress diathesis hypothesis is currently one of the prevailing models of etiology of psychotic disorders. Cortisol is the most researched stress hormone; yet its role in first episode psychosis (FEP) was only recently investigated. The aim of the present study is to systematically review the evidence on the potential role of cortisol in FEP. Higher cortisol levels in blood samples have been consistently replicated, whereas saliva studies measuring baseline cortisol levels have exhibited divergent results. Moreover, longitudinal studies have revealed a cortisol upregulation in FEP with a subsequent decrease induced by antipsychotic treatment. The evidence suggests a role for cortisol in psychosis, although the association of cortisol with psychopathological symptoms is currently non-specific. Future research should focus on more pure diagnostic entities, clearly defined stages of the disorder and refined methods of hormonal measurement.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25200986     DOI: 10.1007/s11920-014-0503-7

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  75 in total

1.  Childhood parental divorce and cortisol in young adulthood: evidence for mediation by family income.

Authors:  Amy J Kraft; Linda J Luecken
Journal:  Psychoneuroendocrinology       Date:  2009-05-13       Impact factor: 4.905

2.  Selective impairments in the stress response in schizophrenic patients.

Authors:  L M Jansen; C C Gispen-de Wied; R S Kahn
Journal:  Psychopharmacology (Berl)       Date:  2000-04       Impact factor: 4.530

3.  Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis.

Authors:  C Kirschbaum; B M Kudielka; J Gaab; N C Schommer; D H Hellhammer
Journal:  Psychosom Med       Date:  1999 Mar-Apr       Impact factor: 4.312

4.  Increased stress-induced dopamine release in psychosis.

Authors:  Romina Mizrahi; Jean Addington; Pablo M Rusjan; Ivonne Suridjan; Alvina Ng; Isabelle Boileau; Jens C Pruessner; Gary Remington; Sylvain Houle; Alan A Wilson
Journal:  Biol Psychiatry       Date:  2011-11-30       Impact factor: 13.382

5.  Effect of antipsychotic treatment on Insulin-like Growth Factor-1 and cortisol in schizophrenia: a longitudinal study.

Authors:  Ganesan Venkatasubramanian; Seetharamaiah Chittiprol; Narendran Neelakantachar; Taranath Shetty; Bangalore N Gangadhar
Journal:  Schizophr Res       Date:  2010-03-11       Impact factor: 4.939

Review 6.  Schizophrenia: a neural diathesis-stress model.

Authors:  E F Walker; D Diforio
Journal:  Psychol Rev       Date:  1997-10       Impact factor: 8.934

7.  Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-naive schizophrenia.

Authors:  Ganesan Venkatasubramanian; Seetharamaiah Chittiprol; Narendran Neelakantachar; Magadi N Naveen; Jagadisha Thirthall; Bangalore N Gangadhar; K Taranath Shetty
Journal:  Am J Psychiatry       Date:  2007-10       Impact factor: 18.112

8.  Increased circulatory dehydroepiandrosterone and dehydroepiandrosterone-sulphate in first-episode schizophrenia: relationship to gender, aggression and symptomatology.

Authors:  Rael D Strous; Rachel Maayan; Raya Lapidus; Leonid Goredetsky; Ella Zeldich; Moshe Kotler; Abraham Weizman
Journal:  Schizophr Res       Date:  2004-12-01       Impact factor: 4.939

9.  Diminished cortisol responses to psychosocial stress associated with lifetime adverse events a study among healthy young subjects.

Authors:  Bernet M Elzinga; Karin Roelofs; Marieke S Tollenaar; Patricia Bakvis; Johannes van Pelt; Philip Spinhoven
Journal:  Psychoneuroendocrinology       Date:  2007-12-21       Impact factor: 4.905

10.  Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment.

Authors:  Valeria Mondelli; Paola Dazzan; Nilay Hepgul; Marta Di Forti; Monica Aas; Alessandro D'Albenzio; Marco Di Nicola; Helen Fisher; Rowena Handley; Tiago Reis Marques; Craig Morgan; Serena Navari; Heather Taylor; Andrew Papadopoulos; Katherine J Aitchison; Robin M Murray; Carmine M Pariante
Journal:  Schizophr Res       Date:  2009-09-13       Impact factor: 4.939

View more
  7 in total

1.  Vitamin D deficiency, behavioral atypicality, anxiety and depression in children with chromosome 22q11.2 deletion syndrome.

Authors:  L Kelley; A F P Sanders; E A Beaton
Journal:  J Dev Orig Health Dis       Date:  2016-12       Impact factor: 2.401

2.  Disrupted glucocorticoid--Immune interactions during stress response in schizophrenia.

Authors:  Joshua Chiappelli; Qiaoyun Shi; Priyadurga Kodi; Anya Savransky; Peter Kochunov; Laura M Rowland; Katie L Nugent; L Elliot Hong
Journal:  Psychoneuroendocrinology       Date:  2015-09-12       Impact factor: 4.905

3.  The relationship between cannabis use and cortisol levels in youth at ultra high-risk for psychosis.

Authors:  Emily E Carol; Robert L Spencer; Vijay A Mittal
Journal:  Psychoneuroendocrinology       Date:  2017-05-30       Impact factor: 4.905

Review 4.  Childhood Trauma, the HPA Axis and Psychiatric Illnesses: A Targeted Literature Synthesis.

Authors:  Felim Murphy; Anurag Nasa; Dearbhla Cullinane; Kesidha Raajakesary; Areej Gazzaz; Vitallia Sooknarine; Madeline Haines; Elena Roman; Linda Kelly; Aisling O'Neill; Mary Cannon; Darren William Roddy
Journal:  Front Psychiatry       Date:  2022-05-06       Impact factor: 5.435

5.  Evidence for Hypothalamus-Pituitary-Adrenal Axis and Immune Alterations at Prodrome of Psychosis in Males.

Authors:  Evangelos Karanikas; Evangelos Ntouros; Dimitrios Oikonomou; Georgios Floros; Ioannis Griveas; Georgios Garyfallos
Journal:  Psychiatry Investig       Date:  2017-09-11       Impact factor: 2.505

6.  The status of serum cortisol before and after treatment of schizophrenia and its correlation to disease severity and improvement: A longitudinal study.

Authors:  Yohannes Markos Woldesenbet; Arefayne Alenko; Iyasu Tadesse Bukata; Lealem Gedefaw; Chaltu Fikru
Journal:  SAGE Open Med       Date:  2021-11-09

Review 7.  Inflammation, Stress Response, and Redox Dysregulation Biomarkers: Clinical Outcomes and Pharmacological Implications for Psychosis.

Authors:  Stefania Schiavone; Luigia Trabace
Journal:  Front Psychiatry       Date:  2017-10-25       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.